Equine estrogens differentially prevent neuronal cell death induced by glutamate

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 5, 2003, Pages 302-308

  Bhavnani, Bhagu R ^a   Berco, Mauricio ^a   Binkley, Julie ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Equine estrogen; Glutamate neurotoxicity; HT22 cells; Neurodegeneration; Neurons; Neuroprotective effects of estrogens; Neurotransmitter; PC12

Indexed keywords

17ALPHA DIHYDROEQUILENIN; 17ALPHA ESTRADIOL; 17BETA DIHYDROEQUILENIN; 17BETA DIHYDROEQUILIN; DELTA8 ESTRONE; DELTA8,17BETA ESTRADIOL; DIHYDROEQUILIN; EQUILENIN; EQUILIN; ESTRADIOL; ESTROGEN DERIVATIVE; ESTRONE; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; ENZYME ASSAY; HIPPOCAMPUS; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUILENIN; EQUILIN; ESTRADIOL; ESTRADIOL CONGENERS; ESTRONE; GLUTAMIC ACID; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038688830     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(03)00087-X     Document Type: Article

References (41)

1. Fonnun F. Glutamate A neurotransmitter in mammalian brain . J Neurochem. 42:1984;1-11.
2. Coyle J.T., Puttfracken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
3. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Progr Brain Res. 100:1994;47-51.
4. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med. 330:1994;613-622.
5. Froissard P., Duval D. Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int. 24:1994;485-493.
6. Davis J.B., Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652:1994;169-173.
7. Behl C., Widmann M., Trapp J., Holsboer F. 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun. 216:1995;473-482.
8. Lezoualch F, Skutella T, Widmann M, Behl C. Melatonin prevents oxidative stress-induced cell death in hippocampal cells. Neuro Rep 1996;2071-7.
9. Tyurin VA, Tyurina YY, Quinn PJ, et al. Glutamate-induced cytotoxicity in PC12 pheochroma cytoma cells: Role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. Brain Res Mol Brain Res 1998;60:270-81.
10. Zanlyanov L.L., Green P.S., Simpkins J.W. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation An in vitro model for assessment of the neuroprotective effects of estrogens . Cell Mol Neurobiol. 19:1999;765-818.
11. Nicotera P., Ankarcrona M., Bonjoco E., Orrenius S., Lipton S.A. Neuronal necrosis and apoptosis Two distinct events induced by exposure to glutamate or oxidative stress . Adv Neurol. 72:1997;95-101.
12. Subbiah M.T., Kessel B., Agrawal M., Rajan R., Abplanalp W., Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 77:1993;1095-1097.
13. Wilcox J.Y., Hwang J., Hodis H.N., Sevanian A., Lobo R.A. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low density lipoproteins. Fertil Steril. 64:1997;57-62.
14. Bhavnani B.R., Cecutti A., Gerulath A., Woolever A.C. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and propucol on low-density lipoprotein oxidation in postmenopausal women. Menopause. 8:2001;408-419.
15. Berco M., Bhavnani B.R. Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death. J Soc Gynecol Investig. 8:2001;245-254.
16. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
17. Slivka A., Cohen G. Hydroxyl radical attack on dopamine. J Biol Chem. 260:1985;15466-15472.
18. Pagahini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol. 140:1994;251-256.
19. Henderson V.W. The epidemilogy of estrogen replacement therapy and Alzheimer's disease. Neurology. 48(Suppl):1997;S27-S35.
20. Tang M.X., Jacobs D., Stern Y., et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
21. Kawas C., Resnick S., Morrison A., et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease The Baltimore Logitudinal Study of Aging . Neurology. 48:1997;1517-1521.
22. Bhavnani B.R. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens Chemistry and metabolism . Proc Soc Exp Biol Med. 217:1998;6-16.
23. Bhavnani B.R., Cecutti A., Gerulath A. Pharmacokinetics and pharmacodynamics of a novel estrogen delta-8-estrone in postmenopausal women and men. J Steroid Biochem Mol Biol. 67:1998;119-131.
24. Greene L.A., Tischler A.S. Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 73:1976;2424-2428.
25. Greene P.S., Gordon D., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effect of steroids. J Steroid Biochem Mol Biol. 63:1997;229-235.
26. Moosmann B., Behl C. The antioxidant neuroprotective effect of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A. 96:1999;8867-8872.
27. Behl C., Skutella T., Lezoual C.F., Post A., Widmann M., Newton C.J. Neuroprotection against oxidative stress by estrogens Structure-activity relationship . Mol Pharmacol. 51:1997;535-541.
28. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotection by estratrienes. A novel interaction with glutathione. Lett Neurosci. 84:1998;7-10.
29. Bhavnani B.R., Nisker J.A., Martin J., Alelebi F., Watson L., Milne J.K. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (Premarin) and a synthetic mixture of estrogens (C:E.S) in postmenopausal women. J Soc Gynecol Investig. 7:2000;175-183.
30. Behl C. Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res. 69:1999;213-219.
31. Chen J., Adachi N., Liu K., Arai T. The effect of 17β-estradiol on ischemia-induced neuronal damage in the gerbil hippocampus. Neuroscience. 87:1998;817-822.
32. Nilsen J., Mor G., Naftolin F. Raloxifen induces neurite outgrowth in estrogen receptor positive cells PC12 cells. Menopause. 5:1998;211-216.
33. Gursoy E., Cardounel A., Al-Khlaiwi A., Al-drees A., Kalimi M. Tamoxifen protects clonal mouse hippocampal (HT22) cells against neurotoxin-induced cell death. Neurochem Int. 40:2002;405-412.
34. 2+ currents in aortic smooth muscle cells. Eur J Pharmacol. 294:1995;625-635.
35. Mermelstein P.Y., Becker J.B., Surmeier D.J. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci. 16:1996;595-604.
36. Woolley C., McEwen B.S. Estradiol regulates hippocampal dentritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 14:1994;7580-7687.
37. O'Malley C.A., Hantamaki R.D., Kelley M., Meyer E.M. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, A Ch synthesis, and release from rat cerebral cortical synaptosomes. Brain Res. 403:1987;389-392.
38. Pentitti N., Karkanial G., Etgen A.M. Estradiol selectively regulates alpha1β-noradrenergic receptors in the hypothalamus and preoptic area. J Neurosci. 12:1992;3869-3876.
39. Panikark S., Guan G., King M.A., Rajakumar G., Simpkins J.W. 17β-estradiol attenuates CREB decline in rat hippocampus following seizure. J Neurobiol. 33:1997;961-967.
40. Auer R.N., Kalimo H., Olsson Y., Siesjo B.J. The temporal evolution of hypoglycemic brain damage. II. Light and electron-microscopic findings in the hippocampal gyrus and subiculum of the rat. Acta Neuropathol. 67:1985;25-36.
41. Singh M., Meyer E.M., Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of the female Sprague-Dawley rats. Endocrinology. 136:1995;2320-2324.